66 FR 141 pg. 38226 - Hematology and Pathology Devices; Reclassification of Automated Differential Cell Counters; Correction
Type: PRORULEVolume: 66Number: 141Page: 38226
Docket number: [Docket No. 95P-0315]
FR document: [FR Doc. 01-18343 Filed 7-20-01; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR 864
[Docket No. 95P-0315]
Hematology and Pathology Devices; Reclassification of Automated Differential Cell Counters; Correction
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Proposed rule; correction.
SUMMARY:
The Food and Drug Administration (FDA) is correcting a proposed rule that appeared in the Federal Register of May 9, 2001 (66 FR 23634). The document proposes to reclassify from class III (premarket approval) to class II (special controls) the automated differential cell counter (ADCC). The document published inadvertently with the incorrect docket number. This document corrects that error.
FOR FURTHER INFORMATION CONTACT:
Joyce Strong, Office of Policy, Planning, and Legislation (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.
SUPPLEMENTARY INFORMATION:
In FR Doc. 01-11580, appearing in the Federal Register of Wednesday, May 9, 2001, the following correction is made: On page 23634, in the second column, "[Docket No. 95P-0351]" is corrected to read "[Docket No. 95P-0315]."
Dated: July 17, 2001.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 01-18343 Filed 7-20-01; 8:45 am]
BILLING CODE 4160-01-S